These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 16050141)

  • 21. Antibodies to extractable nuclear antigens (ENAS) in systemic lupus erythematosus patients: correlations with clinical manifestations and disease activity.
    Emad Y; Gheita T; Darweesh H; Klooster P; Gamal R; Fathi H; El-Shaarawy N; Gamil M; Hawass M; El-Refai RM; Al-Hanafi H; Abd-Ellatif S; Ismail A; Rasker J
    Reumatismo; 2018 Jul; 70(2):85-91. PubMed ID: 29976042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concentration of antibodies to extractable nuclear antigens and disease activity in systemic lupus erythematosus.
    Agarwal S; Harper J; Kiely PD
    Lupus; 2009 Apr; 18(5):407-12. PubMed ID: 19318392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic criteria for systemic lupus erythematosus: a critical review.
    Yu C; Gershwin ME; Chang C
    J Autoimmun; 2014; 48-49():10-3. PubMed ID: 24461385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibodies Targeting Ficolin-2 in Systemic Lupus Erythematosus Patients With Active Nephritis.
    Colliard S; Jourde-Chiche N; Clavarino G; Sarrot-Reynauld F; Gout E; Deroux A; Fougere M; Bardin N; Bouillet L; Cesbron JY; Thielens NM; Dumestre-Pérard C
    Arthritis Care Res (Hoboken); 2018 Aug; 70(8):1263-1268. PubMed ID: 29045037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of autoantibodies in pediatric-onset systemic lupus erythematosus and their relationship with disease-associated manifestations.
    Gilliam BE; Ombrello AK; Burlingame RW; Pepmueller PH; Moore TL
    Semin Arthritis Rheum; 2012 Jun; 41(6):840-8. PubMed ID: 22177108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-tubulin-α-1C autoantibody in systemic lupus erythematosus: a novel indicator of disease activity and vasculitis manifestations.
    Zhao X; Cheng Y; Gan Y; Jia R; Zhu L; Sun X
    Clin Rheumatol; 2018 May; 37(5):1229-1237. PubMed ID: 29427009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
    Pradhan VD; Patwardhan MM; Ghosh K
    Indian J Dermatol Venereol Leprol; 2010; 76(2):145-9. PubMed ID: 20228543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoantibodies associated with RNA are more enriched than anti-dsDNA antibodies in circulating immune complexes in SLE.
    Ahlin E; Mathsson L; Eloranta ML; Jonsdottir T; Gunnarsson I; Rönnblom L; Rönnelid J
    Lupus; 2012 May; 21(6):586-95. PubMed ID: 22300829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential clearance mechanisms, neutrophil extracellular trap degradation and phagocytosis, are operative in systemic lupus erythematosus patients with distinct autoantibody specificities.
    Chauhan SK; Rai R; Singh VV; Rai M; Rai G
    Immunol Lett; 2015 Dec; 168(2):254-9. PubMed ID: 26434792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus.
    Yee CS; Hussein H; Skan J; Bowman S; Situnayake D; Gordon C
    Rheumatology (Oxford); 2003 Feb; 42(2):276-9. PubMed ID: 12595622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?
    To CH; Petri M
    Arthritis Rheum; 2005 Dec; 52(12):4003-10. PubMed ID: 16320348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study on the association of autoantibodies, chemokine, and its receptor with disease activity in systemic lupus erythematosus in North Indian population.
    Bidyalaxmi Devi L; Bhatnagar A; Wanchu A; Sharma A
    Rheumatol Int; 2013 Nov; 33(11):2819-26. PubMed ID: 23832290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two major autoantibody clusters in systemic lupus erythematosus.
    Ching KH; Burbelo PD; Tipton C; Wei C; Petri M; Sanz I; Iadarola MJ
    PLoS One; 2012; 7(2):e32001. PubMed ID: 22363785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoantibodies against the replication protein A complex in systemic lupus erythematosus and other autoimmune diseases.
    Yamasaki Y; Narain S; Hernandez L; Barker T; Ikeda K; Segal MS; Richards HB; Chan EK; Reeves WH; Satoh M
    Arthritis Res Ther; 2006; 8(4):R111. PubMed ID: 16846524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. International multi-center evaluation of a novel chemiluminescence assay for the detection of anti-dsDNA antibodies.
    Bentow C; Lakos G; Martis P; Wahl E; Garcia M; Viñas O; Espinosa G; Cervera R; Sjöwall C; Carmona-Fernandes D; Santos MJ; Hanly JG; Mahler M
    Lupus; 2016 Jul; 25(8):864-72. PubMed ID: 27252263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome-Wide Assessment of Differential DNA Methylation Associated with Autoantibody Production in Systemic Lupus Erythematosus.
    Chung SA; Nititham J; Elboudwarej E; Quach HL; Taylor KE; Barcellos LF; Criswell LA
    PLoS One; 2015; 10(7):e0129813. PubMed ID: 26192630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study on the correlation between anti-ribosomal P protein antibody and systemic lupus erythematosus.
    Wang Y; Luo P; Guo T; Zou L; Shi J; Chen P
    Medicine (Baltimore); 2020 May; 99(20):e20192. PubMed ID: 32443340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-nucleosome antibodies in patients with systemic lupus erythematosus: potential utility as a diagnostic tool and disease activity marker and its comparison with anti-dsDNA antibody.
    Saigal R; Goyal LK; Agrawal A; Mehta A; Mittal P; Yadav RN; Meena PD; Wadhvani D
    J Assoc Physicians India; 2013 Jun; 61(6):372-7. PubMed ID: 24640201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibody-based subgroups and longitudinal seroconversion in juvenile-onset systemic lupus erythematosus.
    Bao S; Huang H; Jin Y; Ding F; Yang Z; Xu X; Liu C; Lu J; Jin Y
    Lupus Sci Med; 2023 Apr; 10(1):. PubMed ID: 37012058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between clinical manifestations and serological profile in patients affected by Systemic Lupus Erythematosus.
    Nicola S; Borrelli R; Corradi F; Lo Sardo L; Badiu I; Romito A; Rashidy N; Quinternetto A; Mazzola M; Meli F; Saracco E; Vitali I; Cosseddu D; Brussino L
    Front Immunol; 2024; 15():1390642. PubMed ID: 39221240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.